In April 2018 Sport Ireland (Spórt Éireann) has reported an anti-doping rule violation against the Canadian Athlete IS-5671 after her sample tested positive for the prohibited substances 1,3-Dimethylbutylamine (1,3-DMBA) and Higenamine. After notification the Athlete gave a prompt admission, waived her right to be heard and accepted the sanction proposed by Sport Ireland.
The Athlete explained with evidence that during her stay in Ireland she had used a supplement (XMBurn) as replacement for her B12 supplement she was using in Canada. As she believed that she had used a B12 supplement she mentioned this on the Doping Control Form. She demonstrated with internet webpage evidence that the supplement in question contained Higenamine and DMBA.
Sport Ireland accepts the Athlete’s explanation and evidence and finds that she established No Significant Fault or Negligence and how the substances entered her system. Here Sport Ireland also finds that the Athlete conducted insufficient research and checks of this supplement before using.
Considering the Athlete’s degree of fault and her prompt admission Sport Ireland decides on 14 August 2018 to impose a 14 month period of ineligibility on the Athlete IS-5671 starting on the date of the sample collection, i.e. on 29 October 2017.
